Metabolic dysfunction-associated steatotic liver disease and omega-6 polyunsaturated fatty acids: Friends or foes

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

244

Figures (1-3)

Tables (1-2)

Sum=300

Publishing Process of This Article

Item

Count

Browse

Download

Sum=2

Mar 27, 2025 (publication date) through Apr 1, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Hepatol. Mar 27, 2025; 17(3): 102286
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.102286

Full Size Figure Download Figure

Figure 3 Omega-6 polyunsaturated fatty acid subtypes. ELOVL: Elongation of very long chain fatty acids.

Citation: Hegazy MA, Ahmed SM, Sultan SM, Afifi OF, Mohamed MA, Azab AE, Hassanen MA, Zaben RK. Metabolic dysfunction-associated steatotic liver disease and omega-6 polyunsaturated fatty acids: Friends or foes. World J Hepatol 2025; 17(3): 102286
URL: https://www.wjgnet.com/1948-5182/full/v17/i3/102286.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i3.102286